Peginterferon-α-2a (40kD) and ribavirin in patients with chronic hepatitis C: A phase II open-label study

Mark Sulkowski, Robert Reindollar, David L. Thomas, Sherilyn Brinkley-Laughton, Martha Hudson, Jian Yu

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Peginterferon-α-2a (40kD) and ribavirin in patients with chronic hepatitis C: A phase II open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences